DNA Array-Based Gene Profiling in Tumor Immunology
暂无分享,去创建一个
[1] F. Marincola,et al. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. , 2004, Cytokine & growth factor reviews.
[2] F. Marincola,et al. Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. , 2003, Biochimica et biophysica acta.
[3] K. Elenitoba-Johnson,et al. Validation of cDNA microarray gene expression data obtained from linearly amplified RNA , 2003, Molecular pathology : MP.
[4] J. Ioannidis,et al. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment , 2003, The Lancet.
[5] Soldano Ferrone,et al. Tumors as elusive targets of T-cell-based active immunotherapy. , 2003, Trends in immunology.
[6] F. Marincola,et al. Quantitative real-time PCR: a powerful ally in cancer research. , 2003, Trends in molecular medicine.
[7] G. Parmiani,et al. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues. , 2003, Cancer research.
[8] May D. Wang,et al. GoMiner: a resource for biological interpretation of genomic and proteomic data , 2003, Genome Biology.
[9] S. Reed,et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer , 2003, British Journal of Cancer.
[10] T. Whiteside,et al. Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] Jun Luo,et al. Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays , 2003, Cancer investigation.
[12] D. Slonim. From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.
[13] G. Churchill. Fundamentals of experimental design for cDNA microarrays , 2002, Nature Genetics.
[14] Yusuke Nakamura,et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. , 2002, Cancer research.
[15] C. Nguyen,et al. Gene Profiling Approach to Establish the Molecular Bases for Partial versus Full Activation of Naïve CD8 T Lymphocytes , 2002, Annals of the New York Academy of Sciences.
[16] J. Xiang,et al. DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells. , 2002, Life sciences.
[17] Hans-Georg Rammensee,et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. , 2002, Cancer research.
[18] S K Libutti,et al. Advantages of mRNA amplification for microarray analysis. , 2002, BioTechniques.
[19] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[20] Yingdong Zhao,et al. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. , 2002, Cancer research.
[21] F. Marincola,et al. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration , 2002, Genome Biology.
[22] Yuyu Kuang,et al. Conserved codon composition of ribosomal protein coding genes in Escherichia coli, Mycobacterium tuberculosis and Saccharomyces cerevisiae: lessons from supervised machine learning in functional genomics. , 2002, Nucleic acids research.
[23] G. Schuler,et al. Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells , 2002, The Journal of experimental medicine.
[24] N. Broude. Differential display in the time of microarrays , 2002, Expert review of molecular diagnostics.
[25] U. Scherf,et al. Large-scale gene expression analysis in molecular target discovery , 2002, Leukemia.
[26] J. Xiang,et al. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. , 2002, Cancer research.
[27] Drew M. Pardoll,et al. Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.
[28] M. Atkins,et al. Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy , 2002, Journal of immunotherapy.
[29] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[30] J. Xiang,et al. Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. , 2002, Biochemical and biophysical research communications.
[31] J. Gordon,et al. DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. , 2001, Cellular immunology.
[32] S. Reed,et al. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma , 2001, Oncogene.
[33] K R Hess,et al. Microarrays: handling the deluge of data and extracting reliable information. , 2001, Trends in biotechnology.
[34] K. Anderson,et al. Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium. , 2001, Current molecular medicine.
[35] A. Giuliani,et al. The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data , 2001, FEBS letters.
[36] R. Ciubotariu,et al. Distinct mRNA microarray profiles of tolerogenic dendritic cells. , 2001, Human immunology.
[37] F. Marincola,et al. Cytokines and Immune Response in the Tumor Microenvironment , 2001, Journal of immunotherapy.
[38] R. Steinman,et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.
[39] Antonio Lanzavecchia,et al. Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.
[40] K. Furge,et al. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Brazma,et al. Gene expression data analysis. , 2001, FEBS letters.
[42] F. Marincola,et al. Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness , 2001, International journal of cancer.
[43] C. Akdis,et al. Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.
[44] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[45] Steven A. Rosenberg,et al. Progress in human tumour immunology and immunotherapy , 2001, Nature.
[46] J. Dopazo,et al. Methods and approaches in the analysis of gene expression data. , 2001, Journal of immunological methods.
[47] Yudong D. He,et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.
[48] Søren Buus,et al. Tumor‐associated antigens identified by mRNA expression profiling induce protective anti‐tumor immunity , 2001, European journal of immunology.
[49] O. Kallioniemi,et al. Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.
[50] M. Mayford,et al. A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse. , 2001, Nucleic acids research.
[51] E. Brown,et al. Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.
[52] F. Marincola,et al. A natural history of melanoma: serial gene expression analysis. , 2000, Immunology today.
[53] Jiasen Lu,et al. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. , 2000, Nucleic acids research.
[54] G. A. Whitmore,et al. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[56] F. Marincola,et al. Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100 , 2000, Journal of immunotherapy.
[57] A. Toulouse,et al. RARβ involvement in enhancement of lung tumor cell immunogenicity revealed by array analysis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[58] G. Sherlock. Analysis of large-scale gene expression data. , 2000, Current opinion in immunology.
[59] K. Margolin. Interleukin-2 in the treatment of renal cancer. , 2000, Seminars in oncology.
[60] F. Marincola,et al. High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.
[61] M Roederer,et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[62] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[63] T. Hughes,et al. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. , 2000, Science.
[64] S. Lederman,et al. T Suppressor Lymphocytes Inhibit NF-κB-Mediated Transcription of CD86 Gene in APC , 1999, The Journal of Immunology.
[65] A. Enk,et al. Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma , 1999, The Journal of experimental medicine.
[66] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[67] F. Bertucci,et al. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.
[68] R. Fisher,et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] S. Lederman,et al. Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. , 1999, Human immunology.
[70] P. Törönen,et al. Analysis of gene expression data using self‐organizing maps , 1999, FEBS letters.
[71] D. Morton,et al. Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in‐transit melanoma metastases , 1999, Cancer.
[72] Goldenfeld,et al. Simple lessons from complexity , 1999, Science.
[73] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[74] G. Pennesi,et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. , 1998, Journal of immunology.
[75] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[76] A. Lanzavecchia. Licence to kill , 1998 .
[77] Zhuoru Liu,et al. Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. , 1998, International immunology.
[78] F. Marincola,et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma , 1998, Nature Medicine.
[79] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[80] P. Nurse,et al. Reductionism: The ends of understanding , 1997, Nature.
[81] P. Walker,et al. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. , 1997, Journal of immunology.
[82] E. Petricoin,et al. Laser Capture Microdissection , 1996, Science.
[83] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[84] Ronald W. Davis,et al. Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.
[85] R. Henderson,et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.
[86] P. Singer. Licence to kill , 1994, Nature.
[87] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[88] S. Rosenberg,et al. Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. , 1989, Journal of immunology.
[89] S. Rosenberg,et al. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. , 1988, Journal of immunology.
[90] F. Marincola,et al. The dual role of IL-10. , 2003, Trends in immunology.
[91] M. Smyth,et al. Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection , 2002, Nature Immunology.
[92] M Vingron,et al. Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31 , 500-Element cDNA Array , 2001 .
[93] Andreas D. Baxevanis,et al. The Molecular Biology Database Collection: an updated compilation of biological database resources , 2001, Nucleic Acids Res..
[94] F. Le Naour. Contribution of proteomics to tumor immunology. , 2001, Proteomics.
[95] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[96] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.
[97] D. Botstein,et al. The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.
[98] D. Botstein,et al. Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.
[99] S. Lederman,et al. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. , 1999, Journal of immunology.
[100] S. Rosenberg,et al. Human melanoma cells do not express Fas (Apo-1/CD95) ligand. , 1999, Cancer research.
[101] D. Lockhart,et al. Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.
[102] P. Anderson. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. , 1995, Current topics in microbiology and immunology.
[103] D. Pardoll. Paracrine cytokine adjuvants in cancer immunotherapy. , 1995, Annual review of immunology.
[104] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[105] O RAJKA,et al. [TUMOR IMMUNOLOGY]. , 1963, Orvosi hetilap.